Plants – Talk Bio

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

3 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)

Catalent Sells New Jersey Facility and HQ to Ardena, Expanding Belgian CDMO’s US Footprint

6 months ago talkbio0Tagged Ardena, Catalent, CDMO, expansion, HQ, Jersey manufacturing, pharmaceutical manufacturing, Plants

Catalent, Ardena, New Jersey manufacturing plant, HQ sale, CDMO expansion, pharmaceutical manufacturing

UCB Divests Chinese Production Plant and Older Medications for $680 Million

8 months ago talkbio0Tagged China, Drug Industry, older medications, Plants, production, UCB

UCB, production plant, older medications, China, $680M, pharmaceutical industry, divestment

GenScript ProBio Launches New Gene Therapy Production Plant in New Jersey

10 months ago talkbio0Tagged biotech, CDMO, gene therapy, GenScript ProBio, Plants, production

GenScript ProBio, Gene Therapy, Production Plant, New Jersey, CDMO, Biotech

Eli Lilly Expands Manufacturing Capacity with Nexus Plant Acquisition Amid Ongoing Mounjaro and Zepbound Supply Challenges

12 months ago talkbio0Tagged Acquisition (action), Capacity, Drug Industry, Drug shortages, Eli, Eli Lilly, Manufacture, Mounjaro, Nexus manufacturing, Plants, Wisconsin, Zepbound

Eli Lilly, Nexus manufacturing plant, Wisconsin, Mounjaro, Zepbound, drug shortages, manufacturing capacity, pharmaceutical industry, acquisition

Lonza closes plant in China but CDMO’s sales signal an uptick in industry

1 year ago talkbio0Tagged China, Immunostimulating conjugate (antigen), Industry, Plants, Signal

Plants, China, Signal, Industry, Congestive heart failure